Skip to main content
. 2015 Aug;88(2):273–280. doi: 10.1124/mol.115.098707

TABLE 1.

Effects of mutations within the two pyrethroid receptor sites on the action of DMT and PMT

Symbols ↓, ↑, and ≈ indicate decrease, increase, or insignificant change of the ligand potency, respectively.

PyR1
PyR2
Mutant Ref.a DMT PMT Mutant Ref.a DMT PMT
L2k7F/I 1 ↓/↓ ≈ /↑ I1k7A 3
M2k11T 1 V1k11A 3
S1o2A 5
L2o6I 1 L1o6I/A 3,5 ↑/≈ ≈/↑
T2o10I 1 I1o10C 3
L2o13F 1 T1o13W 3
C2o14A 1
V2i18G 3 L1i18G 3
F2i22Sb 5 I1i22A 5
L2i25A 5 I1i25A 5
L2i26A 5
S1i29A 5
I3i12A 2 V2i12A/L 5 ≈/↑ ↑/↑
F3i13C 3 I2i13M 3
S3i15A 2 N2i15S 5
F3i16A 2 L2i16F/S 3 ↓/↓ ↓/↓
F3i17I 4
N3i20A 2 N2i20A 5
a

References: 1 (Usherwood et al., 2007); 2 (Du et al., 2009); 3 (Du et al., 2013) and references therein; 4 (Tan et al., 2005); and 5, this study (Figs. 3B and 4).

b

F2i22 contributes to both PyR1 and PyR2.